Lyu et al. demonstrated that tumor-derived exosomal PD-L1 interacts with PD-1 receptors on T cells, suppressing their activation and inducing T cell exhaustion, which plays a significant role in resistance to immune CPIs in cancers such as NSCLC and melanoma [171,172]. This evidence concerns the gene CD274 and melanoma.